These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24424270)

  • 1. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
    Hou H; Nieto A; Ma F; Freeman WR; Sailor MJ; Cheng L
    J Control Release; 2014 Mar; 178():46-54. PubMed ID: 24424270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sustained dual drug delivery system for proliferative vitreoretinopathy.
    Xiao Y; Choi KS; Warther D; Huffman K; Landeros S; Freeman WR; Sailor MJ; Cheng L
    Drug Deliv; 2020 Dec; 27(1):1461-1473. PubMed ID: 33100053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.
    Hou H; Wang C; Nan K; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):557-66. PubMed ID: 26882530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
    Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
    Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.
    Hartmann KI; Nieto A; Wu EC; Freeman WR; Kim JS; Chhablani J; Sailor MJ; Cheng L
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):493-500. PubMed ID: 23448595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.
    Nieto A; Hou H; Moon SW; Sailor MJ; Freeman WR; Cheng L
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1070-80. PubMed ID: 25613937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.
    Wang C; Hou H; Nan K; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2014 Dec; 129():74-82. PubMed ID: 25446320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system.
    Chhablani J; Nieto A; Hou H; Wu EC; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1268-79. PubMed ID: 23322571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy.
    Warther D; Xiao Y; Li F; Wang Y; Huffman K; Freeman WR; Sailor M; Cheng L
    Drug Deliv; 2018 Nov; 25(1):1537-1545. PubMed ID: 29996687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics.
    Hou H; Huffman K; Rios S; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2755-63. PubMed ID: 25829415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles.
    Nieto A; Hou H; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2013 Nov; 116():161-8. PubMed ID: 24036388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies.
    Moon SW; Sun Y; Warther D; Huffman K; Freeman WR; Sailor MJ; Cheng L
    Drug Deliv; 2018 Jan; 25(1):600-610. PubMed ID: 29461171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sustained intravitreal drug delivery system with remote real time monitoring capability.
    Hou H; Nieto A; Belghith A; Nan K; Li Y; Freeman WR; Sailor MJ; Cheng L
    Acta Biomater; 2015 Sep; 24():309-21. PubMed ID: 26087110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of multifunctional porous silica nanocarriers for pH/enzyme-responsive drug release.
    Qiu L; Zhang W; Wang S; Zhang X; Zhao Y; Cao L; Sun L
    Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():485-491. PubMed ID: 28888002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained delivery of a HIF-1 antagonist for ocular neovascularization.
    Iwase T; Fu J; Yoshida T; Muramatsu D; Miki A; Hashida N; Lu L; Oveson B; Lima e Silva R; Seidel C; Yang M; Connelly S; Shen J; Han B; Wu M; Semenza GL; Hanes J; Campochiaro PA
    J Control Release; 2013 Dec; 172(3):625-33. PubMed ID: 24126220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitability of porous silicon microparticles for the long-term delivery of redox-active therapeutics.
    Wu EC; Andrew JS; Buyanin A; Kinsella JM; Sailor MJ
    Chem Commun (Camb); 2011 May; 47(20):5699-701. PubMed ID: 21503283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme/GSH/pH-responsive hyaluronic acid grafted porous silica nanocarriers bearing Ag
    Hou J; Zhao Y; Sun L; Zou X
    Carbohydr Polym; 2023 Apr; 305():120547. PubMed ID: 36737216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles.
    Wang J; Chen B; Chen J; Cai X; Xia G; Liu R; Chen P; Zhang Y; Wang X
    Int J Nanomedicine; 2011; 6():203-11. PubMed ID: 21445276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrastive Studies of Cytarabine/Daunorubicin Dual-Loaded Liposomes Prepared by pH Gradient and Cu
    Zhang J; Zhou L; Zhang Y; He H; Yin T; Gou J; Wang Y; Tang X
    AAPS PharmSciTech; 2020 Nov; 21(8):325. PubMed ID: 33206247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.